Harrington, J., Carnicelli, A., Hua, K., Hong, H., Lopes, R. D., Patel, M. R., … Granger, C. B. (2022). NOAC USE IS SAFE AND EFFECTIVE FOR PATIENTS WITH ATRIAL FIBRILLATION AND REDUCED RENAL FUNCTION: RESULTS FROM COMBINE-AF. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 79, pp. 36–36).

Harrington, Josephine, Anthony Carnicelli, Kaiyuan Hua, Hwanhee Hong, Renato D. Lopes, Manesh R. Patel, Robert P. Giugliano, Lars Wallentin, and Christopher B. Granger. “NOAC USE IS SAFE AND EFFECTIVE FOR PATIENTS WITH ATRIAL FIBRILLATION AND REDUCED RENAL FUNCTION: RESULTS FROM COMBINE-AF.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 79:36–36, 2022.

Harrington J, Carnicelli A, Hua K, Hong H, Lopes RD, Patel MR, et al. NOAC USE IS SAFE AND EFFECTIVE FOR PATIENTS WITH ATRIAL FIBRILLATION AND REDUCED RENAL FUNCTION: RESULTS FROM COMBINE-AF. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022. p. 36–36.

Harrington, Josephine, et al. “NOAC USE IS SAFE AND EFFECTIVE FOR PATIENTS WITH ATRIAL FIBRILLATION AND REDUCED RENAL FUNCTION: RESULTS FROM COMBINE-AF.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 79, no. 9, 2022, pp. 36–36.

Harrington J, Carnicelli A, Hua K, Hong H, Lopes RD, Patel MR, Giugliano RP, Wallentin L, Granger CB. NOAC USE IS SAFE AND EFFECTIVE FOR PATIENTS WITH ATRIAL FIBRILLATION AND REDUCED RENAL FUNCTION: RESULTS FROM COMBINE-AF. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022. p. 36–36.